Wordt geladen...
Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia
Background: Phosphoinositide 3-kinase inhibitors (PI3Ki) are a new class of medications used to treat HR positive, HER2 negative, PIK3CA mutated advanced or metastatic breast cancer. Inhibition of PI3K, a key enzyme in the insulin signaling pathway, leads to disruption of glucose metabolism and freq...
Bewaard in:
| Gepubliceerd in: | J Endocr Soc |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089671/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.803 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|